The effect of berberine sulfate on healthy mice infected with Candida albicans.
D000284:Administration, Oral; D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use; D001600:Berberine Alkaloids / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002176:Candida albicans / Q000187:drug effects*; D002177:Candidiasis / Q000188:drug therapy / Q000473:pathology; D004064:Digestive System; D005753:Gastric Mucosa / Q000473:pathology; D007274:Injections, Intraperitoneal; D007668:Kidney / Q000473:pathology; D008099:Liver / Q000473:pathology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009092:Mucous Membrane / Q000473:pathology; D013154:Spleen / Q000473:pathology
D000935:Antifungal Agents; D001600:Berberine Alkaloids